Here’s a good question that gets at a concept you should understand: tumor cell differentiation. (more…)
Okay, we talked about how to remember the components of nephrotic syndrome and nephritic syndrome. But what causes these syndromes?
Let’s boil it down to the top causes.
Nephrotic syndrome can be caused by renal diseases or systemic diseases (like diabetes). We’ll just discuss the renal diseases here. All of these diseases are characterized by a loss of foot processes (look it up in a physiology textbook if you’ve forgotten what these are). The three main renal diseases are:
1. Minimal change disease. This is the number one cause of nephrotic syndrome in children. The pathogenesis is unknown. It’s called minimal change (or sometimes “nil”) disease because under light microscopy, the glomeruli look pretty normal! Prognosis is good.
2. Focal segmental glomerulosclerosis. This disorder can be primary, or it may be associated with other conditions (like HIV, or heroin use). It’s called focal segmental glomerulosclerosis because if you look at a kidney biopsy, some (“focal”) glomeruli show partial (“segmental”) hyalinization. The pathogenesis is unknown, and unlike minimal change disease, the prognosis is generally poor.
3. Membranous glomerulonephritis. This type of glomerular disease is really an autoimmune reaction against some unknown renal antigen. Immune complexes are formed and are deposited along the glomerular basement membrane, which appears thickened on light microscopy. If you look at an electron micrograph, you’ll see subepithelial deposits, or “spikes.”
There are two main causes of nephritic syndrome. Both are immunologically mediated, and are characterized by proliferative changes and inflammation in the glomeruli. These causes are:
1. Postinfectious glomerulonephritis. This used to be called post-Streptococcal glomerulonephritis, because it most commonly occurs in children following a case of Strep throat. There’s a rather crude, but useful, mnemonic for this disease: sore throat (Strep infection), face bloat (edema), pee coke (patients often have brown-colored urine). Immune complexes are formed (the antigen is unknown, but probably is some type of Streptococcal protein) and deposited in the glomerular basement membrane (you can see the deposits on electron microscopy; they look like subepithelial humps). On light microscopy, the glomeruli look big and hypercellular, with lots of inflammatory cells. Recovery occurs in most children.
2. IgA nephropathy. This is also called Berger disease. It’s the most common glomerular disease worldwide, and it’s one of the most common causes of recurrent hematuria. It usually occurs in children or young adults, and it presents as hematuria following an upper respiratory infection. Patients with this disease produce abnormally high IgA levels; following an infection, you can see this IgA in the mesangium of the glomerulus (using immunofluorescent stains for IgA). Once IgA gets trapped there, complement is activated, and we all know what that does (bad stuff). The prognosis is variable.
There are, of course, other causes of nephrotic and nephritic syndrome (nothing is ever that easy!). But if you remember the main causes listed above, that should serve you very well.
Note: the photo of coca-cola bottles was taken by DeusXFlorida and can be found at http://www.flickr.com/photos/8363028@N08/3029152878/.
Here’s one of those things in pathology that will lead you to pull all your hair out: what is the difference between nephrotic and nephritic syndrome? (more…)
We talked recently about differentiation. Here’s another new word to learn: anaplasia.
Q. What is the connection between dysplasia and neoplasia? I understand that dysplasia is a precancerous condition. Grades I and II are not neoplastic. But grade III dysplasia, also called carcinoma in situ, is neoplastic, right? But is it a true carcinoma, or is it not at that point malignant?
A. Dysplasia is not a neoplastic process. While it is often a precursor to neoplasia, not all cases will evolve into malignancy (e.g., mild cervical dysplasia usually does not progress to carcinoma. We watch patients who have it carefully, though, to catch those patients that do go down that path.).
Carcinoma in situ is neoplastic. The cells in carcinoma in situ have the potential to invade (and definitely will, if left alone and untreated). They have acquired enough genetic mutations to have the characteristics of malignant cells (they are able to invade, able to grow on their own without growth signals, insensitive to growth-inhibiting signals, able to metastasize, etc).
Some classification schemes equate grade III dysplasia with carcinoma in situ, while others leave carcinoma in situ in its own category at the far end of the nastiness spectrum. Personally, I prefer the latter way of looking at things, because keeps the separation between dysplasia and neoplasia intact.
The important thing to remember, no matter what semantics you choose, is that the chances of evolution into overt carcinoma rise with the degree of dysplasia. Mild dysplasia usually does not evolve into carcinoma, whereas severe dysplasia usually does.
The image above shows a portion of cervical epithelium that has undergone dysplastic change. The right hand side of the image shows normal squamous epithelium, and the left hand side of the image shows moderately dysplastic epithelium. The dysplastic epithelial cells are pleomorphic (varying in size and shape) and hyperchromatic (darkly-staining) nuclei. Their architecture is also disrupted. Instead of the nice basal layer and orderly maturation and flattening-out of cells that you see in normal epithelium, much of the epithelial thickness resembles the basal layer.
Q. My professor asked this on an exam: What’s the difference in molecular mechanism between metaplasia and neoplasia?
A. Metaplasia is the changing of one cell type to another. The term is used most often in reference to epithelial cells, for example, when the normal glandular epithelium of the cervix is replaced with squamous epithelium, it is called “squamous metaplasia”. It simply means that the basal cells (the stem cells of the epithelial layer) switch from making one type of epithelial cell to another.
Though it is not malignant or even premalignant, in and of itself, metaplasia sometimes indicates that there has been damage to the area, and if the insult continues, dysplasia or even frank malignancy can occur. This is fairly common in the lung: metaplasia of the bronchial epithelium is followed by dysplasia, which is followed by carcinoma. The molecular mechanisms of this whole process of metaplasia are not well understood.
“Neoplasia” literally means “new growth.” Neoplastic cells have several characteristics that make them nasty: they grow autonomously without any need for growth signals, they are insensitive to normal growth-inhibitory signals, they don’t die off like they should, they are capable of limitless replication, and – if they are malignant neoplastic cells – they invade vessels and travel to different parts of the body and set up shop.
There are lots of molecular mechanisms (and corresponding genetic mutations) that underlie these neoplastic qualities; most neoplasms have several such mutations. A cancer cell can have mutations in many different genes – for example, the genes encoding growth factor receptors, signal-transducing proteins, nuclear transcription factors, or cyclins.
Sometimes these mutations turn on a gene that promotes growth. The normal variants of these growth-promoting genes are called “proto-oncogenes” and the mutated variants are called “oncogenes.” An example of just such a gene is the RAS proto-oncogene, which makes a signal transduction protein involved in cell growth. Many neoplasms have a mutated RAS gene (called the RAS oncogene) that has been altered in such a way that it is always turned on. Which means that the cells containing the mutation are always transducing growth signals, and always growing and dividing.
Another type of mutation can occur in genes (called “tumor suppressor genes”) that normally put brakes on cell growth. An example of this type of gene is the retinoblastoma tumor-suppressor gene, which normally stops cells at the G1 checkpoint in the cell cycle. In certain tumors, the retinoblastoma gene is mutated in such a way that it doesn’t work. Cells that have this mutated gene proceed without pause through the G1 checkpoint, heading full-tilt on to mitosis.
So, to summarize: the molecular mechanisms of metaplasia are not well understood. The molecular mechanisms underlying neoplasia are numerous and complex.
Rudolf Virchow, a German pathologist in the 1800s, is considered by many to be “the father of pathology.” His famous Omnis cellula e cellula (“every cell originates from another existing cell like it”) theory, published in1858, rejected the then-prevalent belief that organisms could spontaneously arise from non-living matter (e.g., that maggots could spontaneously appear in decaying meat). (more…)
The term “left shift” means that a particular population of cells is “shifted” towards more immature precursors (meaning that there are more immature precursors present than you would normally see). (more…)
Recent Comments